Cardiol Therapeutics | WebDisclosure

PRESS RELEASE

published on 02/27/2024 at 14:16, 2 years 4 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates BUY recommendation on Cardiol Therapeutics Inc. FDA grants Orphan Drug Designation for CardiolRx in pericarditis treatment. Positive phase II study results expected in Q2 2024

FDA Cardiol Therapeutics Inc First Berlin Equity Research Orphan Drug Designation Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 4 months ago

Cardiol Therapeutics Receives FDA Orphan Drug Designation for CardiolRx

FDA Investment Orphan Drug Designation Cardiol Therapeutics Pericarditis
BRIEF

published on 02/27/2024 at 14:16, 2 years 4 months ago

Cardiol Therapeutics obtient la désignation de médicament orphelin par la FDA pour CardiolRx

Investissement FDA Orphan Drug Designation Cardiol Therapeutics Pericardite
PRESS RELEASE

published on 01/19/2024 at 12:41, 2 years 6 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research has published an update on Cardiol Therapeutics Inc., reaffirming its BUY recommendation and maintaining the price target of USD 3.60. The report highlights the progress in patient recruitment for CardiolRx's two lead indications, acute myocarditis (AM) and recurrent pericarditis (RP), with expectations of significant near-term catalysts for the stock. Analyst Christian Orquera remains optimistic about the company's investment potential. For the full analysis, visit the link provided.

Cardiol Therapeutics Inc First Berlin Equity Research Buy Recommendation Patient Recruitment Investment Potential
PRESS RELEASE

published on 08/30/2023 at 15:06, 2 years 10 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 05/24/2023 at 13:01, 3 years 1 month ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 04/11/2023 at 15:26, 3 years 3 months ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): Buy

Published on 07/22/2026 at 15:00, 1 hour 3 minutes ago

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 1 hour 3 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:50, 1 hour 13 minutes ago

Hillcrest Enters AI Datacenter Ecosystem
Published on 07/22/2026 at 14:35, 1 hour 28 minutes ago

Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 1 hour 33 minutes ago

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

View all ACCESSWIRE

Published on 07/22/2026 at 15:59, 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 07/22/2026 at 15:58, 5 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 07/22/2026 at 15:57, 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 07/22/2026 at 15:56, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Rotork plc
Published on 07/22/2026 at 15:55, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS

Published on 07/22/2026 at 15:26, 37 minutes ago

Chiffres d'Affaires du 1er Trimestre de l'Exercice 2026/2027
Published on 07/22/2026 at 08:03, 8 hours ago

Availability of the 2026 Interim Results Report
Published on 07/22/2026 at 08:03, 8 hours ago

Mise à disposition du Rapport Financier Semestriel 2026
Published on 07/22/2026 at 08:00, 8 hours 3 minutes ago

Neoen launches construction of Narrogin Wind Farm in Western Australia after signing PPA with Synergy
Published on 07/22/2026 at 08:00, 8 hours 3 minutes ago

Neoen lance la construction du parc éolien de Narrogin en Western Australia après avoir signé un PPA avec Synergy

View all LES ECHOS COMFI WIRE

News